Question 10710 — pharmacy and medications

Summary

Ms. Marina Ferrari questions the Minister of Health and Prevention on the cost of anticancer drugs and on their unit dispensation (DAU). According to the health insurance report on the evolution of costs and products for 2024, the treatment of cancers represented a cost of 22.6 billion euros to health insurance in 2021. In addition, among all pathologies, the largest increase between 2015 and 2021 is observed on the treatment of cancers (+7.2 billion euros). This increase is largely due to the reimbursement of anticancer drugs. Although the national agreement of dispensing pharmacists, which came into force on May 7, 2022, encourages in particular the DAU of medicines, anticancer treatments are not subject to such dispensation, which generates difficulties in managing the medicines for the patients themselves or the healthcare establishments on which they depend, with waste which results in unnecessary public expenditure. Furthermore, the construction of the price of these treatments raises questions and risks jeopardizing the budgetary sustainability of the French health insurance system. With the aim of controlling public spending, she would like to know if he plans to implement the DAU for drug treatments against cancer and whether a reform of the construction of the prices of these drugs is under study.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.